Drug Testing in the Identification & Treatment of Substance Use Disorders
Start Date: September 24, 2014
End Date: September 24, 2014
Wednesday, September 24 from 1:00 to 2:00 PM, EST
Steve Passik, PhD, VP of Clinical Research and Advocacy
The emergence of clinical drug testing beyond the “gotcha” forensic approach has offered a clinical tool that advocates for clients and offers scientific data for therapeutic planning. This webinar will highlight recommendations from the American Society of Addiction Medicine’s white paper on drug testing, describe various testing processes, and show how to use testing to support treatment and recovery.
- Articulate how medication monitoring, including urine drug testing (UDT), provides an evidence-based monitoring tool that can enhance the clinician-patient relationship
- Differentiate the clinical value and advantages of various testing methodologies
- Introduce UDT to your patients as a mutually beneficial component of their treatment plan
This webinar qualifies for 1 CE credit.
The SAMHSA-HRSA Center for Integrated Health Solutions (CIHS) does not endorse or attest to the quality of the content. Questions regarding content, recordings, and additional information should be directed to the host organization and/or presenter.
More Info Url: